Compounds > go 6976
Page last updated: 2024-10-28

go 6976 and Experimental Mammary Neoplasms

go 6976 has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, DK2
Martin, KJ1
McAlister, C1
Cruz, AP1
Graner, E2
Dai, SC2
Pardee, AB2
Cruz, A1
Weiser, B1

Other Studies

2 other studies available for go 6976 and Experimental Mammary Neoplasms

ArticleYear
Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.
    Cancer research, 2003, Jan-15, Volume: 63, Issue:2

    Topics: Adenocarcinoma; Animals; Apoptosis; Carbazoles; Female; Gene Expression Profiling; Gene Expression R

2003
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Aug-28, Volume: 98, Issue:18

    Topics: Animals; Base Sequence; Breast Neoplasms; Carbazoles; Cell Division; Cyclin D1; DNA Primers; Enzyme

2001